What is Hereditary Spastic Paraplegia

Hereditary Spastic Paraplegia (HSP) is a group of inherited neurological disorders characterized by progressive weakness and muscle stiffness (spasticity) in the lower limbs due to the degeneration of nerve fibers in the spinal cord.

Understanding the Body Systems Affected

The primary impact of Hereditary Spastic Paraplegia involves the upper motor neurons, which are the nerve cells that carry signals from the brain to the spinal cord. In HSP, the longest axons—those extending to the legs—are most vulnerable. This leads to symptoms such as gait abnormalities, muscle tightness, hyperreflexia, and, in some cases, bladder urgency or peripheral neuropathy.

Classification and Prevalence

Hereditary Spastic Paraplegia is clinically classified into two main types: "pure" HSP, which primarily affects the legs, and "complicated" HSP, where symptoms extend beyond the legs to include cognitive impairment, vision loss, or ataxia. Prevalence estimates vary widely due to the genetic diversity of the condition, but it is generally estimated to affect between 1 and 9 per 100,000 individuals globally.

Who is Affected?

HSP can present at any age, from early childhood to late adulthood. It affects both genders equally and occurs in all ethnic populations worldwide. Because it is a genetic condition, it can be inherited in autosomal dominant, autosomal recessive, or X-linked patterns, depending on the specific gene mutation involved.

Underlying Mechanisms

The pathology of Hereditary Spastic Paraplegia is rooted in "dying-back" axonopathy. This means the nerve cells do not die initially; instead, the ends of the longest nerve fibers degenerate because of defects in intracellular transport, mitochondrial function, or lipid metabolism. This distinguishes HSP from conditions like Multiple Sclerosis, which is characterized by immune-mediated demyelination rather than the primary axonal degeneration seen in HSP.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM)


• Hereditary Spastic Paraplegia Foundation